UBS Group
TMDX icon

UBS Group’s Transmedics TMDX Stock Holding History

UBS Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.4K Hold
1,000
– – ﹤0.01% 7420
2026
Q1 		$99.4K Buy
+1,000
New +$130K ﹤0.01% 7003

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

UBS Group's TMDX Position: Q2 2026 in Review

UBS Group reduced its Transmedics (TMDX) stake by 16% in Q2 2026, selling an estimated $7.85M and leaving 488,058 shares worth $32.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2188.

UBS Group first reported a position in TMDX in Q2 2019 and has held it in 29 quarters since. The position peaked at $96.1M in Q3 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • UBS Group held 488,058 shares of Transmedics worth $32.4M as of Q2 2026.
  • UBS Group sold 92,735 Transmedics shares in Q2 2026, an estimated $7.85M.
  • Transmedics made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2188 holding.
  • UBS Group first reported a position in Transmedics in Q2 2019 and has held it in 29 quarters since.
  • UBS Group's Transmedics position peaked at $96.1M in Q3 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.